ISMIE - News and Articles

10/24/23

Telemedicine Flexibilities Pertaining to Controlled Substances Extended Again!

Now the DEA and the Department of Health and Human Services have initiated a Second Temporary Rule to extend the expiration date to Dec. 31, 2024.

View

05/16/23

DEA Extends Telehealth Flexibility Pertaining to Controlled Substances

A pandemic-era policy that allows physicians to prescribe controlled substances in a telehealth visit has been extended to Nov. 11, 2023.

View

02/07/23

Free 18-Month Program Aims to Improve Cancer Diagnostics Via Telemedicine

To learn more, register for one of AHRQ’s informational webinars, available on numerous dates and times through May 2023.

View

The extension, now running through the end of 2025, is a win for physicians and patients.

View